The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient derived xenografts of upper tract urothelial carcinoma: A potential tool for personalized medicine.
 
Kwanghee Kim
No Relationships to Disclose
 
Katie S Murray
No Relationships to Disclose
 
Aditya Bagrodia
No Relationships to Disclose
 
Francois Audenet
No Relationships to Disclose
 
Sylvia Jebiwott
No Relationships to Disclose
 
Benjamin Gordon
No Relationships to Disclose
 
Alex Somma
No Relationships to Disclose
 
Stephen LaRosa
No Relationships to Disclose
 
Yiyu Dong
No Relationships to Disclose
 
Ricardo Alvim
No Relationships to Disclose
 
A. Ari Hakimi
No Relationships to Disclose
 
James Hsieh
Honoraria - Chugai Pharma
Consulting or Advisory Role - Chugai Pharma; Eisai; Novartis
Research Funding - CGI; Novartis; Pfizer
 
Hikmat Al-Ahmadie
Consulting or Advisory Role - Genentech
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Illumina; Merck
Honoraria - UpToDate
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Johnson & Johnson; Lilly; Merck; Oncogenex; Onyx
Research Funding - Agensys; Genentech; Mirati Therapeutics; Oncogenex
Patents, Royalties, Other Intellectual Property - ERCC2 predicting cisplatin sensitivity
Travel, Accommodations, Expenses - Genentech/Roche
 
David B. Solit
Honoraria - Loxo; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Jonathan Coleman
No Relationships to Disclose